- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04561700
Nutritive Sucking Patterns in Premature Infants
January 6, 2022 updated by: Ariel A. Salas, University of Alabama at Birmingham
Nutritive Sucking Patterns in Premature Infants: A Randomized Trial
In this pilot trial, the investigators will determine the feasibility of monitoring nutritive sucking patterns to facilitate the transition from tube to oral feeding in extremely-low-birth weight (ELBW) infants
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Detailed Description
In this parallel-group randomized controlled trial, ELBW infants (birthweight < 1000 grams) will be randomly assigned in a 1:1 ratio to either weekly reporting on objective measurements of sucking activity during oral feeding (intervention group) or usual care without information on sucking activity (control group).
Study Type
Interventional
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 week to 1 month (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Birthweight < 1000 grams
- Gestational age < 32 weeks of gestation
- Full enteral feeding established before or on postnatal day 21
- Oral feeding initiated before or at 33 weeks of postmenstrual age
Exclusion Criteria:
- Major congenital/chromosomal anomalies
- Patent ductus arteriosus causing significant cardiovascular symptoms
- History of necrotizing enterocolitis stage 2 or greater
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Reporting of sucking patterns captured by Instrumented Bottle
Weekly reporting on objective measurements of sucking activity during oral feeding
|
In the intervention group, data on nutritive sucking and feeding cues captured by the Instrumented Bottle will be made available to speech therapists to document the feeding session and provide written recommendations in their weekly report.
|
Sham Comparator: Control
Weekly reporting on traditional measurements of sucking activity during oral feeding (no objective measurements reported)
|
In the control group, the information captured by the Instrumented Bottle will not be made available to speech therapists and therefore, will not be used to document a feeding session or provide weekly recommendations.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time to independent oral feeding
Time Frame: Birth to 120 days
|
Time interval in days from introduction of oral feeding to full independent oral feeding
|
Birth to 120 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Postnatal age at discharge
Time Frame: Birth to 120 days
|
Age in days at the time of hospital discharge
|
Birth to 120 days
|
Length of hospital stay
Time Frame: Birth to 120 days
|
Total number of hospitalization days
|
Birth to 120 days
|
Growth rate during the transition from tube to oral feeding
Time Frame: Birth to 120 days
|
Weekly weight gain in g/kg/day
|
Birth to 120 days
|
Tube feeding events per day during the transition from tube to oral feeding.
Time Frame: Birth to 120 days
|
Daily count of tube feeding events
|
Birth to 120 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
October 1, 2021
Primary Completion (Anticipated)
July 1, 2022
Study Completion (Anticipated)
June 1, 2023
Study Registration Dates
First Submitted
September 5, 2020
First Submitted That Met QC Criteria
September 19, 2020
First Posted (Actual)
September 24, 2020
Study Record Updates
Last Update Posted (Actual)
January 10, 2022
Last Update Submitted That Met QC Criteria
January 6, 2022
Last Verified
January 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 300004412
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Premature
-
Ascendance BiomedicalCompletedInfertility | Menopause | Menopause, Premature | Infertility, Female | Premature Ovarian Failure | Menopause Related Conditions | Perimenopausal Disorder | Infertility Unexplained | Menopause Premature Symptomatic | Menopause Premature Asymptomatic | Premature Ovarian Failure, Familial | Premature Ovarian Failure... and other conditionsUnited States
-
Forever Young d.o.o.Medigroup Health System, Jevremova hospital; Saint James Hospital Malta; Re-medika...UnknownMenopause | Menopause, Premature | Premature Ovarian Failure | Ovarian Failure, Premature | Ovarian Failure | Ovarian Insufficiency | Ovarian Insufficiency, Primary | Premature Ovarian Failure 2A | Premature Ovarian Failure 3 | Premature Ovarian Failure 4 | Premature Ovarian Failure 1 | Premature Ovarian Failure... and other conditionsMalta, North Macedonia, Serbia
-
GlaxoSmithKlineCompletedObstetric Labour, Premature | Premature LaborUnited States
-
Assistance Publique Hopitaux De MarseilleUnknownPremature LabourFrance
-
Assiut UniversityNot yet recruitingPremature Rupture of Membrane
-
Cairo UniversityCompletedPremature Rupture of MembraneEgypt
-
University of OklahomaIndiana University School of MedicineCompletedPreterm Premature Rupture of Membranes
-
University of CalgaryCanadian Institutes of Health Research (CIHR); Alberta Economic Development...TerminatedMicrobiota | Gastrointestinal Microbiome | Infant, Premature | Infants, Extremely PrematureCanada
-
Ain Shams UniversityUnknownRupture of Membranes; PrematureEgypt
-
sarah mohamed hassanHend Mostafa Hussein SalemCompletedPremature Rupture of MembraneEgypt